NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

抗精神病藥的全球市場:各藥物類別,各應用領域,各地區的市場規模調查與預測(2021年∼2027年)

Global Antipsychotic Drugs Market Size study, Antipsychotic Drugs Market by Drug Class, by Application and Regional Forecasts 2021-2027

出版商 Bizwit Research & Consulting LLP 商品編碼 1008763
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
抗精神病藥的全球市場:各藥物類別,各應用領域,各地區的市場規模調查與預測(2021年∼2027年) Global Antipsychotic Drugs Market Size study, Antipsychotic Drugs Market by Drug Class, by Application and Regional Forecasts 2021-2027
出版日期: 2021年05月25日內容資訊: 英文
簡介

全球抗精神病藥的市場規模2020年約126億7,000萬美金,2021年∼2027年的預測期間內預計以1.95%以上的健全成長率成長。

抗精神病藥,也稱為精神穩定劑,用於治療精神分裂症並減輕雙相情感障礙與其他疾病的症狀。隨著雙相、妄想等精神障礙病例的不斷增加,以及抗精神病藥物研究的不斷創新,推動抗精神病藥物市場的成長。精神障礙患者受到污名化、歧視和侵犯人權的現像很普遍,人們不願意尋求幫助。這可能會限制其成長。然而,政府日益努力提高對治療和接受精神障礙患者的認識,這可能會成為未來十年抗精神病藥物市場的機會。

本報告提供抗精神病藥的世界市場調查,市場概要,市場成長要素及阻礙因素分析,市場機會,各藥物類別、應用、地區的市場規模的變化與預測,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 摘要整理

第2章 市場定義和範圍

第3章 市場動態

  • 市場影響分析(2019年∼2027年)

第4章 產業分析

  • 波特的五力分析
  • PEST分析
  • 投資採用模式
  • 分析師的推薦事項與結論

第5章 各類藥物

  • 市場概述
  • 效能:潛力分析
  • 市場規模預測:2018年∼2027年(10億美元單位)
  • 子區隔分析
    • 第一世代/標準/典型抗精神病藥物
    • 第二世代/非典型抗精神病藥物
    • 第三代抗精神病藥
    • 其他的市場

第6章 各應用領域

  • 市場概述
  • 效能:潛力分析
  • 市場規模預測:2018年∼2027年(10億美元單位)
  • 子區隔分析
    • 思覺失調症
    • 躁鬱症
    • 憂鬱症
    • 失智症
    • 其他

第7章 各地區

  • 地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲的概述
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲
  • 亞太地區的概述
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他亞太地區
  • 南美的概述
    • 巴西
    • 墨西哥
  • 其他地區

第8章 競爭資訊

  • 最高市場策略
  • 企業簡介
    • Johnson & Johnson
    • Pfizer, Inc.
    • Eli Lilly & Co.
    • Bristol-Myers Squibb Company
    • AstraZeneca
    • Glaxo SmithKline, Plc
    • Allergan
    • Otsuka Pharmaceutical Co., Ltd.
    • Sumitomo Dainippon Pharma Co., Ltd.
    • Vanda Pharmaceuticals Inc.

第9章 調查流程

目錄

Global Antipsychotic Drugs Market is valued approximately USD 12.67 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 1.95% over the forecast period 2021-2027. A "psychotic disorder" is an umbrella term to describe multiple types of mental health conditions that involve a phenomenon called psychosis. The word 'psychosis' is used to describe conditions that affect the mind, where there has been some loss of contact with reality. It can be caused by some medications, alcohol or drug abuse. Schizophrenia, a common type, has patients often experiencing delusions or hallucinations. Antipsychotic drugs, also called tranquilizers, are prescribed to treat schizophrenia and to reduce the symptoms of bipolar and other disorders. With the growing cases of psychotic disorders such as bipolar, delusions etc. as well as continuous innovations in research of antipsychotic drugs are driving the growth of Antipsychotic Drugs market. According to World Health Organization, Schizophrenia affects 20 million people globally and usually starts earlier among men. In 2019, almost 69% of people with schizophrenia are not receiving suitable care. In 2019, 90% of people with untreated schizophrenia live in low- and middle- income countries. Also, lack of access to mental health services is an important issue. Stigma, discrimination and violation of human rights of people with psychotic disorders is common and people doesn't incline to seek help. This may act as a restraint for its growth. However, increasing efforts from government to raise awareness for the treatment and acceptance of psychotic disorder patients may act as an opportunity for Antipsychotic Drugs Market in subsequent decade.

Key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World are analysed to provide a holistic picture of Antipsychotic Drugs Market. Due to greater awareness for mental health issues and disorders as well as higher per capita income, North America has emerged as the significant region across the world in terms of market share. Whereas, Asia-Pacific is expected to exhibit highest growth rate for the forecast period 2021-2027 increasing cases of bipolar and schizophrenic disorders and thus increased demand for antipsychotic drugs. Rising disposable income and growing awareness for mental health issues treatment will also boost growth in this region.

Major market player included in this report are:

Johnson & Johnson

Pfizer, Inc.

Eli Lilly & Co.

Bristol-Myers Squibb Company

AstraZeneca

Glaxo SmithKline, Plc

Allergan

Otsuka Pharmaceutical Co., Ltd.

Sumitomo Dainippon Pharma Co., Ltd.

Vanda Pharmaceuticals Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:

First Generation/Standard/Typical Antipsychotics Drug

Second Generation/Atypical Antipsychotics Drug

Third generation Antipsychotics Drug

Other market

By Application:

Schizophrenia

Bipolar Disorder

Depression

Dementia

Other psychotic disorders

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019

Base year - 2020

Forecast period - 2021 to 2027

Target Audience of the Global Antipsychotic Drugs Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
    • 1.2.1. Antipsychotic Drugs Market, by Drug Class, 2019-2027 (USD Billion)
    • 1.2.2. Antipsychotic Drugs Market, by Application, 2019-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Antipsychotic Drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Antipsychotic Drugs Market Dynamics

  • 3.1. Antipsychotic Drugs Market Impact Analysis (2019-2027)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increased cases of psychotic disorders
      • 3.1.1.2. Increased awareness for mental health and well-being
    • 3.1.2. Market Challenges
      • 3.1.2.1. Stigma attached to mental health disorders
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Governmental support to raise awareness for treatment

Chapter 4. Global Antipsychotic Drugs Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Antipsychotic Drugs Market, by Drug Class

  • 5.1. Market Snapshot
  • 5.2. Global Antipsychotic Drugs Market by Drug Class, Performance - Potential Analysis
  • 5.3. Global Antipsychotic Drugs Market Estimates & Forecasts by Drug Class 2018-2027 (USD Billion)
  • 5.4. Antipsychotic Drugs Market, Sub Segment Analysis
    • 5.4.1. First Generation/Standard/Typical Antipsychotics Drug
    • 5.4.2. Second Generation/Atypical Antipsychotics Drug
    • 5.4.3. Third generation Antipsychotics Drug
    • 5.4.4. Other market

Chapter 6. Global Antipsychotic Drugs Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Antipsychotic Drugs Market by Application, Performance - Potential Analysis
  • 6.3. Global Antipsychotic Drugs Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
  • 6.4. Antipsychotic Drugs Market, Sub Segment Analysis
    • 6.4.1. Schizophrenia
    • 6.4.2. Bipolar Disorder
    • 6.4.3. Depression
    • 6.4.4. Dementia
    • 6.4.5. Other psychotic disorders

Chapter 7. Global Antipsychotic Drugs Market, Regional Analysis

  • 7.1. Antipsychotic Drugs Market, Regional Market Snapshot
  • 7.2. North America Antipsychotic Drugs Market
    • 7.2.1. U.S. Antipsychotic Drugs Market
      • 7.2.1.1. Drug Class breakdown estimates & forecasts, 2018-2027
      • 7.2.1.2. Application breakdown estimates & forecasts, 2018-2027
    • 7.2.2. Canada Antipsychotic Drugs Market
  • 7.3. Europe Antipsychotic Drugs Market Snapshot
    • 7.3.1. U.K. Antipsychotic Drugs Market
    • 7.3.2. Germany Antipsychotic Drugs Market
    • 7.3.3. France Antipsychotic Drugs Market
    • 7.3.4. Spain Antipsychotic Drugs Market
    • 7.3.5. Italy Antipsychotic Drugs Market
    • 7.3.6. Rest of Europe Antipsychotic Drugs Market
  • 7.4. Asia-Pacific Antipsychotic Drugs Market Snapshot
    • 7.4.1. China Antipsychotic Drugs Market
    • 7.4.2. India Antipsychotic Drugs Market
    • 7.4.3. Japan Antipsychotic Drugs Market
    • 7.4.4. Australia Antipsychotic Drugs Market
    • 7.4.5. South Korea Antipsychotic Drugs Market
    • 7.4.6. Rest of Asia Pacific Antipsychotic Drugs Market
  • 7.5. Latin America Antipsychotic Drugs Market Snapshot
    • 7.5.1. Brazil Antipsychotic Drugs Market
    • 7.5.2. Mexico Antipsychotic Drugs Market
  • 7.6. Rest of The World Antipsychotic Drugs Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Johnson & Johnson
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Pfizer, Inc.
    • 8.2.3. Eli Lilly & Co.
    • 8.2.4. Bristol-Myers Squibb Company
    • 8.2.5. AstraZeneca
    • 8.2.6. Glaxo SmithKline, Plc
    • 8.2.7. Allergan
    • 8.2.8. Otsuka Pharmaceutical Co., Ltd.
    • 8.2.9. Sumitomo Dainippon Pharma Co., Ltd.
    • 8.2.10. Vanda Pharmaceuticals Inc.

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Antipsychotic Drugs Market, report scope
  • TABLE 2. Global Antipsychotic Drugs Market estimates & forecasts by Region 2018-2027 (USD Billion)
  • TABLE 3. Global Antipsychotic Drugs Market estimates & forecasts by Drug Class 2018-2027 (USD Billion)
  • TABLE 4. Global Antipsychotic Drugs Market estimates & forecasts by Application 2018-2027 (USD Billion)
  • TABLE 5. Global Antipsychotic Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 6. Global Antipsychotic Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 7. Global Antipsychotic Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 8. Global Antipsychotic Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 9. Global Antipsychotic Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 10. Global Antipsychotic Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 11. Global Antipsychotic Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 12. Global Antipsychotic Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 13. Global Antipsychotic Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 14. Global Antipsychotic Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 15. U.S. Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 16. U.S. Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 17. U.S. Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 18. Canada Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 19. Canada Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 20. Canada Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 21. UK Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 22. UK Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 23. UK Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 24. Germany Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 25. Germany Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 26. Germany Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 27. RoE Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 28. RoE Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 29. RoE Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 30. China Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 31. China Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 32. China Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 33. India Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 34. India Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 35. India Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 36. Japan Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 37. Japan Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 38. Japan Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 39. RoAPAC Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 40. RoAPAC Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 41. RoAPAC Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 42. Brazil Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 43. Brazil Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 44. Brazil Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 45. Mexico Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 46. Mexico Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 47. Mexico Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 48. RoLA Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 49. RoLA Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 50. RoLA Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 51. Row Antipsychotic Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
  • TABLE 52. Row Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 53. Row Antipsychotic Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
  • TABLE 54. List of secondary sources, used in the study of global Antipsychotic Drugs Market
  • TABLE 55. List of primary sources, used in the study of global Antipsychotic Drugs Market
  • TABLE 56. Years considered for the study
  • TABLE 57. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Antipsychotic Drugs Market, research methodology
  • FIG 2. Global Antipsychotic Drugs Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Antipsychotic Drugs Market, key trends 2020
  • FIG 5. Global Antipsychotic Drugs Market, growth prospects 2021-2027
  • FIG 6. Global Antipsychotic Drugs Market, porters 5 force model
  • FIG 7. Global Antipsychotic Drugs Market, pest analysis
  • FIG 8. Global Antipsychotic Drugs Market, value chain analysis
  • FIG 9. Global Antipsychotic Drugs Market by segment, 2018 & 2027 (USD Billion)
  • FIG 10. Global Antipsychotic Drugs Market by segment, 2018 & 2027 (USD Billion)
  • FIG 11. Global Antipsychotic Drugs Market by segment, 2018 & 2027 (USD Billion)
  • FIG 12. Global Antipsychotic Drugs Market by segment, 2018 & 2027 (USD Billion)
  • FIG 13. Global Antipsychotic Drugs Market by segment, 2018 & 2027 (USD Billion)
  • FIG 14. Global Antipsychotic Drugs Market, regional snapshot 2018 & 2027
  • FIG 15. North America Antipsychotic Drugs Market 2018 & 2027 (USD Billion)
  • FIG 16. Europe Antipsychotic Drugs Market 2018 & 2027 (USD Billion)
  • FIG 17. Asia pacific Antipsychotic Drugs Market 2018 & 2027 (USD Billion)
  • FIG 18. Latin America Antipsychotic Drugs Market 2018 & 2027 (USD Billion)
  • FIG 19. Global Antipsychotic Drugs Market, company market share analysis (2020)